With this issue we welcome three members to the distinguished editorial advisory board that has guided Contemporary OB/GYN since its inception.
Yalda Afshar, MD, PhD; Christine Isaacs, MD; and Laura Riley, MD begin their time in lending expertise to the content in these pages and online. You can read more about each remarkable scientist here.
We hope you also will find the content in this issue rich and informative. The Society for Maternal-Fetal Medicine (SMFM) shares its Consult Series #50 on Activity Restriction in obstetric management. Editor-in-Chief Catherine Y. Spong, MD, dedicates her editorial to the topic with an endorsement to put activity restriction to bed – her pun fully intended – as research now is available to provide guidance for practitioners recommending against its routine use.
Practitioners continue to navigate health care in a pandemic, conducting much patient communication virtually. Four doctors from Yale—Linda L. Fan, MD, FACOG; Shefali R. Pathy, MD, MPH; Julia Cron, MD; and Sangini S. Sheth, MD, MPH—offer their guidance on managing the Well Woman visit via telehealth.
In the first article of a two-part series, Amanda Kallen, MD, and Sandra Ann Carson, MD, offer a thorough guide to diagnosing an infertile couple. Watch for next month’s article as well, where they provide a guide for treatment.
Ronald J. Wapner, MD, makes a case for improved carrier screening. Ideally, women of reproductive age would be offered carrier screening before conception to maximize the subsequent reproductive options for carrier couples, he says.
Please let us know what you think of this content; reader feedback is invited by emailing Senior Editor Angie DeRosa at aderosa@mjhlifesciences.com.
__
Mike Hennessy, Sr.
Chairman and Founder, MJH Life Sciences
Postmenopausal urinary incontinence treatment data found lacking
May 6th 2024Discover the findings of a comprehensive study exploring the efficacy of various treatments for postmenopausal urinary incontinence, shedding light on the current research gap and recommending avenues for future investigation.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More